Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration
Eri Saijo, Michael A. Metrick, Shunsuke Koga, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 1, pp. 63-77
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
Marcello Rossi, Niccolò Candelise, Simone Baiardi, et al.
Acta Neuropathologica (2020) Vol. 140, Iss. 1, pp. 49-62
Open Access | Times Cited: 318
Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy
Sofia Lövestam, Fujiet Adrian Koh, Bart van Knippenberg, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 206
Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 189
Cellular and pathological heterogeneity of primary tauopathies
Dah‐eun Chloe Chung, Shanu F. Roemer, Leonard Petrucelli, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 144
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases
Dillon J. Rinauro, Fabrizio Chiti, Michele Vendruscolo, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 47
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
Giuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 38
Fluid biomarkers in frontotemporal dementia: past, present and future
Imogen J. Swift, Aitana Sogorb‐Esteve, Carolin Heller, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 92, Iss. 2, pp. 204-215
Open Access | Times Cited: 102
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
María Stamelou, Gesine Respondek, Nikolaos Giagkou, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 10, pp. 601-620
Closed Access | Times Cited: 96
Progressive supranuclear palsy: Advances in diagnosis and management
David G. Coughlin, Irene Litvan
Parkinsonism & Related Disorders (2020) Vol. 73, pp. 105-116
Open Access | Times Cited: 95
A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases
Michael A. Metrick, Natalia Ferreira, Eri Saijo, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 84
Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases
Klara Kulenkampff, Adriana-M. Wolf Perez, Pietro Sormanni, et al.
Nature Reviews Chemistry (2021) Vol. 5, Iss. 4, pp. 277-294
Closed Access | Times Cited: 84
Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies
Shunsuke Koga, Akihiro Ikeda, Dennis W. Dickson
Neuropathology and Applied Neurobiology (2021) Vol. 48, Iss. 1
Open Access | Times Cited: 59
Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status
Dorota Koníčková, Kateřina Menšíková, Lucie Tučková, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1760-1760
Open Access | Times Cited: 58
Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
Brian D. Hitt, Jaime Vaquer‐Alicea, V Manon, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 57
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 613-640
Open Access | Times Cited: 47
Clinical Spectrum of Tauopathies
Nahid Olfati, Ali Shoeibi, Irene Litvan
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 43
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D. Huey, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 6, pp. 364-376
Open Access | Times Cited: 14
CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders
Chloe Anastassiadis, Iván Martínez-Valbuena, Anna Vasilevskaya, et al.
Neurology (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 11
Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons
Michael A. Metrick, Natalia Ferreira, Eri Saijo, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 46, pp. 23029-23039
Open Access | Times Cited: 75
Potential human transmission of amyloid β pathology: surveillance and risks
Elsa Lauwers, Giovanna Lalli, Sebastian Brandner, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 10, pp. 872-878
Open Access | Times Cited: 61
Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids
Niccolò Candelise, Simone Baiardi, Alessia Franceschini, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 60
In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics
Hong Xu, Mia O’Reilly, Garrett S. Gibbons, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 2, pp. 193-215
Open Access | Times Cited: 43
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease
Tze How Mok, Akın Nihat, Nour K. Majbour, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2570-2583
Open Access | Times Cited: 22
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 22
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases
Alexander Bernhardt, Steffen Tiedt, Daniel Teupser, et al.
EBioMedicine (2023) Vol. 89, pp. 104456-104456
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top